BridgeBio Pharma, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US10806X1028
USD
77.87
38.84 (99.51%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1244470,
    "name": "BridgeBio Pharma, Inc.",
    "stock_name": "BridgeBio Pharma, Inc.",
    "full_name": "BridgeBio Pharma, Inc.",
    "name_url": "stocks-analysis/bridgebio-pharma-inc",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "77.87",
    "chg": 38.84,
    "chgp": "99.51%",
    "dir": 1,
    "prev_price": "39.03",
    "mcapval": "15,060.19",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US10806X1028",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "4.74 M",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bridgebio-pharma-inc-1244470-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "BridgeBio Pharma Hits New 52-Week High of $69.48, Up 139.38%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bridgebio-pharma-hits-new-52-week-high-of-6948-up-13938-3659207",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BridgeBioPharma_priceRelatedfactors_3659207.png",
        "date": "2025-10-30 18:51:02",
        "description": "BridgeBio Pharma, Inc. has achieved a new 52-week high, reflecting a substantial increase in its stock performance over the past year. The company, with a market capitalization of USD 10,715 million, showcases strong operational efficiency despite being currently loss-making, highlighted by its notable return on equity."
      }
    ],
    "total": 22,
    "sid": "1244470",
    "stock_news_url": "https://www.marketsmojo.com/news/bridgebio-pharma-inc-1244470"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available